The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome
Aim:In this study, we aimed to compare osteoprotegerin (OPG) levels in patients with and without polycystic ovary syndrome (PCOS) and to investigate the correlation between OPG levels and cardiovascular risk factors.Methods:A total of 49 patients with PCOS and 31 age- and body mass index-matched hea...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2020-06-01
|
| Series: | Haseki Tıp Bülteni |
| Subjects: | |
| Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-relationship-of-osteoprotegerin-with-cardiovas/38675
|
| _version_ | 1797919364069982208 |
|---|---|
| author | Gültekin Adanaş Aydın Hilal Gülsüm Turan Özsoy |
| author_facet | Gültekin Adanaş Aydın Hilal Gülsüm Turan Özsoy |
| author_sort | Gültekin Adanaş Aydın |
| collection | DOAJ |
| description | Aim:In this study, we aimed to compare osteoprotegerin (OPG) levels in patients with and without polycystic ovary syndrome (PCOS) and to investigate the correlation between OPG levels and cardiovascular risk factors.Methods:A total of 49 patients with PCOS and 31 age- and body mass index-matched healthy controls were included in the study. Blood samples were collected and hormonal and metabolic parameters and OPG levels were analyzed. The carotid intima-media thickness (CIMT) was measured for each patient and control through ultrasonography.Results:The low-density lipoprotein and total cholesterol levels were higher and the Homeostasis Model Assessment-Insulin Index (HOMA-IR) values were higher in patients with PCOS (p=0.002, p=0.037, and p=0.028, respectively). The OPG levels were 4.29 pmol/L and 4.07 pmol/L in the patient and control groups, respectively, indicating no significant difference between the groups. The CIMT was 0.57 in both groups.Conclusion:Our study results suggest that OPG levels appear to be similar in patients with PCOS and healthy controls. Although OPG has been associated with endothelial dysfunction, atherosclerosis and coronary calcification in previous studies, currently not a useful marker for cardiovascular risk analysis in this patient population. |
| first_indexed | 2024-04-10T13:45:25Z |
| format | Article |
| id | doaj.art-400f7fa16f424910a98a66d1ff7389ea |
| institution | Directory Open Access Journal |
| issn | 1302-0072 2147-2688 |
| language | English |
| last_indexed | 2024-04-10T13:45:25Z |
| publishDate | 2020-06-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Haseki Tıp Bülteni |
| spelling | doaj.art-400f7fa16f424910a98a66d1ff7389ea2023-02-15T16:11:00ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882020-06-0158327428010.4274/haseki.galenos.2020.584013049054The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary SyndromeGültekin Adanaş Aydın0Hilal Gülsüm Turan Özsoy1 Bursa Yüksek İhtisas Training and Research Hospital, Clinic of Gynecology and Obstetrics, Bursa, Turkey Bursa Çekirge Public Hospital, Clinic of Radiology, Bursa, Turkey Aim:In this study, we aimed to compare osteoprotegerin (OPG) levels in patients with and without polycystic ovary syndrome (PCOS) and to investigate the correlation between OPG levels and cardiovascular risk factors.Methods:A total of 49 patients with PCOS and 31 age- and body mass index-matched healthy controls were included in the study. Blood samples were collected and hormonal and metabolic parameters and OPG levels were analyzed. The carotid intima-media thickness (CIMT) was measured for each patient and control through ultrasonography.Results:The low-density lipoprotein and total cholesterol levels were higher and the Homeostasis Model Assessment-Insulin Index (HOMA-IR) values were higher in patients with PCOS (p=0.002, p=0.037, and p=0.028, respectively). The OPG levels were 4.29 pmol/L and 4.07 pmol/L in the patient and control groups, respectively, indicating no significant difference between the groups. The CIMT was 0.57 in both groups.Conclusion:Our study results suggest that OPG levels appear to be similar in patients with PCOS and healthy controls. Although OPG has been associated with endothelial dysfunction, atherosclerosis and coronary calcification in previous studies, currently not a useful marker for cardiovascular risk analysis in this patient population. http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-relationship-of-osteoprotegerin-with-cardiovas/38675 osteoprotegerinpolycystic ovary syndromeatherosclerosis |
| spellingShingle | Gültekin Adanaş Aydın Hilal Gülsüm Turan Özsoy The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome Haseki Tıp Bülteni osteoprotegerin polycystic ovary syndrome atherosclerosis |
| title | The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome |
| title_full | The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome |
| title_fullStr | The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome |
| title_full_unstemmed | The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome |
| title_short | The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome |
| title_sort | relationship of osteoprotegerin with cardiovascular risk factors in women with and without polycystic ovary syndrome |
| topic | osteoprotegerin polycystic ovary syndrome atherosclerosis |
| url |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-relationship-of-osteoprotegerin-with-cardiovas/38675
|
| work_keys_str_mv | AT gultekinadanasaydın therelationshipofosteoprotegerinwithcardiovascularriskfactorsinwomenwithandwithoutpolycysticovarysyndrome AT hilalgulsumturanozsoy therelationshipofosteoprotegerinwithcardiovascularriskfactorsinwomenwithandwithoutpolycysticovarysyndrome AT gultekinadanasaydın relationshipofosteoprotegerinwithcardiovascularriskfactorsinwomenwithandwithoutpolycysticovarysyndrome AT hilalgulsumturanozsoy relationshipofosteoprotegerinwithcardiovascularriskfactorsinwomenwithandwithoutpolycysticovarysyndrome |